RecruitingNot ApplicableNCT01855633

Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke


Sponsor

Dongtan Sacred Heart Hospital

Enrollment

48 participants

Start Date

Apr 1, 2013

Study Type

INTERVENTIONAL

Conditions

Summary

Stroke is one of the major causes of death in the World. Many stroke survivors may suffer from long-term sequelae of stroke such as hemiplegia. The effects of rehabilitation therapy are limited. The development of new treatment strategies is essential. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method to stimulate the focal area of the brain for restoring brain function. The aim of this study is to investigate the therapeutic effect of rTMS on the motor recovery in patients with hemiplegic stroke.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Modified TBS rTMS, a medical device called Sham rTMS, and others for people with stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETraditional Theta burst stimulation (TBS)
DEVICEModified TBS rTMS
DEVICESham rTMS

Locations(1)

Dongtan Sacred Heart Hospital

Hwaseong-si, Gyeonggi-do, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01855633


Related Trials